Identification and functional characterization of a novel interleukin 17 receptor

A possible mitogenic activation through ras/mitogen-activated protein kinase signaling pathway

Tie Shi Li, Xue Ni Li, Zhi Jie Chang, Xin Yuan Fu, Li Liu

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Interleukin-17 receptor (IL-17R) is increasingly emerged as a distinct receptor family functioning in diverse cellular processes including inflammation and cancer. In this study, we uncovered a novel member of IL-17R from mouse tissue that was named mouse IL-17RE (mIL-17R). Mouse IL-17RE cDNA is composed of at least 14 exons and presents at least 6 spliced isoforms (mIL-17RE1-6) with a molecular weight ranging from 34.2 to 70.1 kD. Mouse IL-17RE is expressed in limited tissues such as lung, kidney, stomach, intestine and testis, etc., and is mainly localized in the cytoplasm and on cell membrane. IL-17RE can also be detected in numerous tumor cell lines. Importantly, a mitogenic effect was detected in BaF3 cells stably transfected with the chimeric receptor fused by the ectodomain of erythropoietin receptor (EPOR) with the transmembrane and endomain of IL-17RE in a serum-dependent but EPO-independent manner. Moreover, ERK1/2 phosphorylation was significantly up-regulated as the dose of mIL-17RE increased. Specific RNAi targeting at mIL-17RE dramatically inhibited the activation of ERK1/2, indicating that mIL-17RE could functionally activate RAS/MAPK signaling pathway. Using dominant negative MEK (Dn-MEK) or RAS (Dn-RAS) as a signaling blocker, we were able to show that mIL-17RE probably activated RAS/MAPK signaling at or upstream of RAS. Overall, our results strongly indicate that mIL-17RE may belong to a novel growth-receptor like molecule that has the capability to support cellular mitogenesis through RAS/MAPK pathway.

Original languageEnglish
Pages (from-to)1287-1298
Number of pages12
JournalCellular Signalling
Volume18
Issue number8
DOIs
StatePublished - Aug 2006

Fingerprint

Interleukin-17 Receptors
Mitogen-Activated Protein Kinases
Erythropoietin Receptors
Mitogen-Activated Protein Kinase Kinases
RNA Interference
Tumor Cell Line
Intestines
Testis
Exons
Stomach
Protein Isoforms
Cytoplasm
Complementary DNA
Molecular Weight
Phosphorylation
Cell Membrane
Inflammation
Kidney
Lung
Growth

Keywords

  • IL-17RE
  • Mitogenesis
  • RAS/MAPK
  • RNA interference
  • Signaling pathway

ASJC Scopus subject areas

  • Cell Biology

Cite this

Identification and functional characterization of a novel interleukin 17 receptor : A possible mitogenic activation through ras/mitogen-activated protein kinase signaling pathway. / Li, Tie Shi; Li, Xue Ni; Chang, Zhi Jie; Fu, Xin Yuan; Liu, Li.

In: Cellular Signalling, Vol. 18, No. 8, 08.2006, p. 1287-1298.

Research output: Contribution to journalArticle

@article{9e157bef00f84e438c0f7aee9cc37273,
title = "Identification and functional characterization of a novel interleukin 17 receptor: A possible mitogenic activation through ras/mitogen-activated protein kinase signaling pathway",
abstract = "Interleukin-17 receptor (IL-17R) is increasingly emerged as a distinct receptor family functioning in diverse cellular processes including inflammation and cancer. In this study, we uncovered a novel member of IL-17R from mouse tissue that was named mouse IL-17RE (mIL-17R). Mouse IL-17RE cDNA is composed of at least 14 exons and presents at least 6 spliced isoforms (mIL-17RE1-6) with a molecular weight ranging from 34.2 to 70.1 kD. Mouse IL-17RE is expressed in limited tissues such as lung, kidney, stomach, intestine and testis, etc., and is mainly localized in the cytoplasm and on cell membrane. IL-17RE can also be detected in numerous tumor cell lines. Importantly, a mitogenic effect was detected in BaF3 cells stably transfected with the chimeric receptor fused by the ectodomain of erythropoietin receptor (EPOR) with the transmembrane and endomain of IL-17RE in a serum-dependent but EPO-independent manner. Moreover, ERK1/2 phosphorylation was significantly up-regulated as the dose of mIL-17RE increased. Specific RNAi targeting at mIL-17RE dramatically inhibited the activation of ERK1/2, indicating that mIL-17RE could functionally activate RAS/MAPK signaling pathway. Using dominant negative MEK (Dn-MEK) or RAS (Dn-RAS) as a signaling blocker, we were able to show that mIL-17RE probably activated RAS/MAPK signaling at or upstream of RAS. Overall, our results strongly indicate that mIL-17RE may belong to a novel growth-receptor like molecule that has the capability to support cellular mitogenesis through RAS/MAPK pathway.",
keywords = "IL-17RE, Mitogenesis, RAS/MAPK, RNA interference, Signaling pathway",
author = "Li, {Tie Shi} and Li, {Xue Ni} and Chang, {Zhi Jie} and Fu, {Xin Yuan} and Li Liu",
year = "2006",
month = "8",
doi = "10.1016/j.cellsig.2005.10.010",
language = "English",
volume = "18",
pages = "1287--1298",
journal = "Cellular Signalling",
issn = "0898-6568",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Identification and functional characterization of a novel interleukin 17 receptor

T2 - A possible mitogenic activation through ras/mitogen-activated protein kinase signaling pathway

AU - Li, Tie Shi

AU - Li, Xue Ni

AU - Chang, Zhi Jie

AU - Fu, Xin Yuan

AU - Liu, Li

PY - 2006/8

Y1 - 2006/8

N2 - Interleukin-17 receptor (IL-17R) is increasingly emerged as a distinct receptor family functioning in diverse cellular processes including inflammation and cancer. In this study, we uncovered a novel member of IL-17R from mouse tissue that was named mouse IL-17RE (mIL-17R). Mouse IL-17RE cDNA is composed of at least 14 exons and presents at least 6 spliced isoforms (mIL-17RE1-6) with a molecular weight ranging from 34.2 to 70.1 kD. Mouse IL-17RE is expressed in limited tissues such as lung, kidney, stomach, intestine and testis, etc., and is mainly localized in the cytoplasm and on cell membrane. IL-17RE can also be detected in numerous tumor cell lines. Importantly, a mitogenic effect was detected in BaF3 cells stably transfected with the chimeric receptor fused by the ectodomain of erythropoietin receptor (EPOR) with the transmembrane and endomain of IL-17RE in a serum-dependent but EPO-independent manner. Moreover, ERK1/2 phosphorylation was significantly up-regulated as the dose of mIL-17RE increased. Specific RNAi targeting at mIL-17RE dramatically inhibited the activation of ERK1/2, indicating that mIL-17RE could functionally activate RAS/MAPK signaling pathway. Using dominant negative MEK (Dn-MEK) or RAS (Dn-RAS) as a signaling blocker, we were able to show that mIL-17RE probably activated RAS/MAPK signaling at or upstream of RAS. Overall, our results strongly indicate that mIL-17RE may belong to a novel growth-receptor like molecule that has the capability to support cellular mitogenesis through RAS/MAPK pathway.

AB - Interleukin-17 receptor (IL-17R) is increasingly emerged as a distinct receptor family functioning in diverse cellular processes including inflammation and cancer. In this study, we uncovered a novel member of IL-17R from mouse tissue that was named mouse IL-17RE (mIL-17R). Mouse IL-17RE cDNA is composed of at least 14 exons and presents at least 6 spliced isoforms (mIL-17RE1-6) with a molecular weight ranging from 34.2 to 70.1 kD. Mouse IL-17RE is expressed in limited tissues such as lung, kidney, stomach, intestine and testis, etc., and is mainly localized in the cytoplasm and on cell membrane. IL-17RE can also be detected in numerous tumor cell lines. Importantly, a mitogenic effect was detected in BaF3 cells stably transfected with the chimeric receptor fused by the ectodomain of erythropoietin receptor (EPOR) with the transmembrane and endomain of IL-17RE in a serum-dependent but EPO-independent manner. Moreover, ERK1/2 phosphorylation was significantly up-regulated as the dose of mIL-17RE increased. Specific RNAi targeting at mIL-17RE dramatically inhibited the activation of ERK1/2, indicating that mIL-17RE could functionally activate RAS/MAPK signaling pathway. Using dominant negative MEK (Dn-MEK) or RAS (Dn-RAS) as a signaling blocker, we were able to show that mIL-17RE probably activated RAS/MAPK signaling at or upstream of RAS. Overall, our results strongly indicate that mIL-17RE may belong to a novel growth-receptor like molecule that has the capability to support cellular mitogenesis through RAS/MAPK pathway.

KW - IL-17RE

KW - Mitogenesis

KW - RAS/MAPK

KW - RNA interference

KW - Signaling pathway

UR - http://www.scopus.com/inward/record.url?scp=33646358725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646358725&partnerID=8YFLogxK

U2 - 10.1016/j.cellsig.2005.10.010

DO - 10.1016/j.cellsig.2005.10.010

M3 - Article

VL - 18

SP - 1287

EP - 1298

JO - Cellular Signalling

JF - Cellular Signalling

SN - 0898-6568

IS - 8

ER -